MediTope Biosciences' Series B Round

MediTope Biosciences raised a round of funding on October 08, 2015.

MediTope Biosciences is an early stage biotechnology company developing antibody-based cancer therapeutics. The company holds an exclusive worldwide license to a groundbreaking technology platform, de…

Articles about MediTope Biosciences' Series B Round: